Welcome to our dedicated page for Joint SEC filings (Ticker: JYNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Joint Corp. filings document the regulatory record for a public chiropractic-care franchisor and clinic operator. Its 8-K reports cover operating and financial results, earnings presentations, material agreements, and capital-structure matters tied to credit facilities, covenants, restricted payments, and share repurchase capacity.
Proxy and governance filings describe director elections, board nomination matters, executive compensation, equity awards, shareholder voting items, and common-stock ownership disclosures. The company’s formal filings also record agreements related to corporate governance and the financing structure that supports its franchise-focused clinic network.
The Joint Corp. reported a return to profitability for 2025 while accelerating its shift to a franchisor model. Full-year revenue rose to $54.9 million from $52.2 million, with consolidated net income improving to $2.9 million from a loss of $5.8 million. Consolidated Adjusted EBITDA increased 13.9% to $13.0 million.
In the fourth quarter, revenue grew 3.1% to $15.2 million and net income reached $1.0 million. System-wide sales for 2025 were $532.4 million, though comp sales declined 0.4%. The company refranchised 41 clinics, ended the year with 960 locations, and repurchased 1.3 million shares for $11.3 million.
For 2026, guidance calls for system-wide sales between $519 million and $552 million, system-wide comp sales between (3)% and 3%, consolidated Adjusted EBITDA of $12.5–$13.5 million, and 30–35 new franchised clinic openings as it completes its transition to a capital-light, pure-play franchisor model.
Bowman Scott Justin reported acquisition or exercise transactions in this Form 4 filing.
JOINT Corp disclosed that Chief Financial Officer Scott Justin Bowman received a grant of 28,301 shares of common stock as a stock award. These shares are restricted, with 25% scheduled to vest on each of the first four anniversaries of the grant date. Following this award, Bowman directly holds 48,285 common shares.
Razdan Sanjiv Kumar reported acquisition or exercise transactions in this Form 4 filing.
JOINT Corp director and officer Sanjiv Kumar Razdan received a grant of 73,484 shares of Common Stock as a stock award, with no cash paid per share. All of these are restricted shares that vest in four equal installments of 25% on each of the first four anniversaries of the grant date.
After this award, Razdan directly holds 162,516 shares of JOINT Corp common stock. Because this is a compensation-related grant rather than an open-market purchase, it reflects equity-based pay designed to align his interests with shareholders over the multi‑year vesting period.
Joint Corp 10% owner Charles E. Jobson reported an open-market purchase of 15,397 common shares at $8.50 each on February 12, 2026. Following this transaction, he directly holds 1,645,294 common shares. The filing also corrects a previously misstated ownership figure from November 20, 2025.
JOBSON CHARLES E, a more than 10% owner of The Joint Corp. (JYNT), bought additional common shares in an open-market transaction. On February 11, 2026, he purchased 448 common shares at $8.70 per share. Following this trade, he directly owned 1,639,597 common shares.
JOINT Corp’s 10% owner Charles E. Jobson reported open‑market purchases of common stock. He bought 16,753 shares of common stock at $10 per share on January 23, 2026, and 725 shares at $10 per share on January 26, 2026.
After these transactions, Jobson directly owned 1,639,149 shares of JOINT Corp common stock.
The Joint Corp. filed an amended current report to correct its description of a letter agreement with Bandera Partners LLC and Jefferson Gramm. Under the revised summary, the company agreed to include Mr. Gramm in its slate of director nominees for the 2026 annual meeting and to recommend that stockholders vote for his election. Bandera agreed that, until a defined termination date, it will not increase its beneficial ownership above the 3,937,296 shares of common stock it already holds, excluding any equity awards tied to Mr. Gramm’s board service. The agreement lasts until the earlier of thirty days before the nomination notice deadline for the 2027 annual meeting or January 21, 2027.
The Joint Corp. reported entering into a letter agreement on January 5, 2026 with Bandera Partners LLC and Jefferson Gramm. Under this agreement, the company will include Mr. Gramm in its slate of nominees for election to the board of directors at the 2026 annual meeting of stockholders and will recommend that stockholders vote in favor of his election.
The agreement also contains voting commitments and standstill obligations for Bandera, along with restrictions on transfers of Joint Corp. common stock held by Bandera until the agreement ends. The letter agreement will remain in effect until the earlier of thirty days before the director nomination deadline for the 2027 annual meeting or January 21, 2027.
The Joint Corp insider activity: A Schedule 13D/Section 16 reporting person increased their stake in the company. Charles E. Jobson, identified as a 10% owner of The Joint Corp (ticker JYNT), reported buying common stock.
On January 6, 2026, he purchased 5,240 shares of common stock in an open-market transaction coded "P" at a price of $8.89 per share. After this transaction, he beneficially owned 1,621,671 common shares, held in direct ownership form according to the filing.
Skylands Capital, LLC, a Wisconsin-based investment adviser, filed a Schedule 13G reporting a passive ownership stake in The Joint Corp. common stock. As of 12/31/2025, Skylands beneficially owned 890,045 shares, representing 6.0% of the outstanding common stock. Skylands has sole voting and sole dispositive power over all 890,045 shares and no shared voting or dispositive power. The firm certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of The Joint Corp.